Table 1.

Abundance of select ciliary membrane proteins in control and arl13 samples

WTarl13
Coverage (%)Total peptidesUnique peptidesCoverage (%)Total peptidesUnique peptides
 Protein (ID #) N-terminus Exp.1/Exp.2/Exp.3 (average ±) Exp.1/Exp.2/Exp.3 (average ±) Exp.1/Exp.2/Exp.3 (average ±) Exp.1/Exp.2/Exp.3 (average ±) Exp.1/Exp.2/Exp.3 (average ±) Exp.1/Exp.2/Exp.3 (average ±) 
Accumulated PLD mgcasskeev 0/0/26.9 (9.0 ± 15.54) 0/0/7 (2.3 ± 4.04) 0/0/4 (1.33 ± 2.31) 52.9/78.9/57.4 (63.1 ± 13.90) 11/40/35 (28.7 ± 15.50) 10/18/12 (13.3 ± 4.16) 
AMPK mgaccsqpse 0/0/7.5 (2.5 ± 4.3) 0/0/5 (1.7 ± 2.9) 0/0/3 (1 ± 1.7) 32.5/42.1/45.0 (39.8 ± 6.6) 16/34/49 (33 ± 16.5) 14/17/16 (15.7 ± 1.5) 
PLC mgnvfscfet 0/0/0 (0) 0/0/0 (0) 0/0/0 (0) 30.5/45.3/30.9 (35.6 ± 8.4) 22/40/41 (34.3 ± 10.7) 16/18/14 (16 ± 2) 
CDPKK1 mgcvgskeda 0/0/0 (0) 0/0/0 (0) 0/0/0 (0) 13/15.3/20.1 (16.1 ± 3.7) 8/24/28 (20 ± 10.6) 8/11/13 (10.7 ± 2.5) 
Reduced FAP12 mgcgasvmnr 78.2/80.6/72.0 (76.9 ± 4.4) 154/384/462 (333.3 ± 160.1) 53/52/47 (50.7 ± 3.2) 47.8/77.6/71.6 (65.7 ± 15.8) 37/132/289 (127.3 ± 152.7) 27/41/44 (37.3 ± 9.1) 
FAP138 mgcgasvmnr 35.2/41.4/28.1 (34.9 ± 6.6) 10/21/13 (14.7 ± 5.7) 7/9/6 (7.3 ± 1.5) 13.6/0/9.9 (7.8 ± 7.02) 4/0/4 (2.3 ± 2.7) 3/0/2 (1.7 ± 1.5) 
FAP124 mskrtadgst 24.4/25.9/33.1 (27.8 ± 4.6) 21/49/56 (42 ± 18.5) 21/22/27 (23.3 ± 3.2) 0/0/0 (0) 0/0/0 (0) 0/0/0 (0) 
PTP1 mgsgastqvq 15.9/10.2/7.1 (11.1 ± 4.5) 12/10/11 (11 ± 1) 9/6/4 (6.3 ± 2.5) 0/0/0 (0) 0/0/0 (0) 0/0/0 (0) 
WTarl13
Coverage (%)Total peptidesUnique peptidesCoverage (%)Total peptidesUnique peptides
 Protein (ID #) N-terminus Exp.1/Exp.2/Exp.3 (average ±) Exp.1/Exp.2/Exp.3 (average ±) Exp.1/Exp.2/Exp.3 (average ±) Exp.1/Exp.2/Exp.3 (average ±) Exp.1/Exp.2/Exp.3 (average ±) Exp.1/Exp.2/Exp.3 (average ±) 
Accumulated PLD mgcasskeev 0/0/26.9 (9.0 ± 15.54) 0/0/7 (2.3 ± 4.04) 0/0/4 (1.33 ± 2.31) 52.9/78.9/57.4 (63.1 ± 13.90) 11/40/35 (28.7 ± 15.50) 10/18/12 (13.3 ± 4.16) 
AMPK mgaccsqpse 0/0/7.5 (2.5 ± 4.3) 0/0/5 (1.7 ± 2.9) 0/0/3 (1 ± 1.7) 32.5/42.1/45.0 (39.8 ± 6.6) 16/34/49 (33 ± 16.5) 14/17/16 (15.7 ± 1.5) 
PLC mgnvfscfet 0/0/0 (0) 0/0/0 (0) 0/0/0 (0) 30.5/45.3/30.9 (35.6 ± 8.4) 22/40/41 (34.3 ± 10.7) 16/18/14 (16 ± 2) 
CDPKK1 mgcvgskeda 0/0/0 (0) 0/0/0 (0) 0/0/0 (0) 13/15.3/20.1 (16.1 ± 3.7) 8/24/28 (20 ± 10.6) 8/11/13 (10.7 ± 2.5) 
Reduced FAP12 mgcgasvmnr 78.2/80.6/72.0 (76.9 ± 4.4) 154/384/462 (333.3 ± 160.1) 53/52/47 (50.7 ± 3.2) 47.8/77.6/71.6 (65.7 ± 15.8) 37/132/289 (127.3 ± 152.7) 27/41/44 (37.3 ± 9.1) 
FAP138 mgcgasvmnr 35.2/41.4/28.1 (34.9 ± 6.6) 10/21/13 (14.7 ± 5.7) 7/9/6 (7.3 ± 1.5) 13.6/0/9.9 (7.8 ± 7.02) 4/0/4 (2.3 ± 2.7) 3/0/2 (1.7 ± 1.5) 
FAP124 mskrtadgst 24.4/25.9/33.1 (27.8 ± 4.6) 21/49/56 (42 ± 18.5) 21/22/27 (23.3 ± 3.2) 0/0/0 (0) 0/0/0 (0) 0/0/0 (0) 
PTP1 mgsgastqvq 15.9/10.2/7.1 (11.1 ± 4.5) 12/10/11 (11 ± 1) 9/6/4 (6.3 ± 2.5) 0/0/0 (0) 0/0/0 (0) 0/0/0 (0) 

Summary of mass spectrometry analyses of isolated matrix fractions. Only proteins, which were enriched or reduced in all three replicates are shown. Peptide coverage, total peptides identified, number of unique peptides identified, and the corresponding averages across three experiments are listed. PLD, phospholipase D (Cre13.g591900); AMPK, AMP-regulated kinase (Cre16.g657350); PLC, phosphatidylinositol phospholipase C (Cre06.g270200); CDPKK1: calcium/calmodulin-dependent protein kinase kinase (Cre10.g428650); FAP12: flagellar associated protein 12 (Cre09.g390615); FAP138: flagellar associated protein 138 (Cre14.g632350); FAP124: flagellar associated protein 124 (Cre09.g386400); PTP1: protein tyrosine phosphatase 1 (Cre07.g325724).

or Create an Account

Close Modal
Close Modal